This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bohlender, J. Articles by Ganten, D. Search for Related Content PubMed PubMed Citation Articles by Bohlender, J. Articles by Ganten, D.

(Hypertension. 1996;27:535-540.)
© 1996 American Heart Association, Inc.

Articles

Human Renin-Dependent Hypertension in Rats Transgenic for Human Angiotensinogen

Jürgen Bohlender; Joël Ménard; Jürgen Wagner; Friedrich C. Luft; Detlev Ganten

From the Max Delbrück Center for Molecular Medicine and the Franz Volhard Clinic, Virchow Klinikum, Humboldt University, Berlin, Germany, and INSERM U367 (J.M.), Paris, France.

Correspondence to Jürgen Bohlender, MD, Max Delbrück Center for Molecular Medicine, Franz Gross House, Wiltbergstrasse 50, 13122 Berlin-Buch, Germany.

Abstract To examine the utility of rats transgenic for human angiotensinogen in the study of human renin-induced hypertension, we first developed assays to measure both the human and rat renin-angiotensin systems in these rats. We used human and mouse renin, transgenic human angiotensinogen, and the human renin inhibitor Ro 42-5892 to determine human- and rat-specific plasma angiotensinogen concentrations, renin activity, and renin concentration. The assays were validated with rat and human plasma mixed in known amounts and with plasma from rats transgenic for human renin. We then tested the human angiotensinogen–transgenic rats by infusing recombinant human renin over 10 days (50 ng/h, n=4) with osmotic minipumps. High human angiotensinogen transgene expression was found in the liver, brain, kidney, gastrointestinal tract, and aorta, whereas rat angiotensinogen gene expression was detected in the liver and brain. During human renin infusion, blood pressure increased to >200/150 mm Hg. Before infusion, human angiotensinogen was 100-fold greater than rat angiotensinogen (141±73 versus 1.2±0.16 µg angiotensin I/mL); the relation was not changed by renin infusion. Plasma renin activity increased 300-fold; human plasma renin concentration increased to very high levels (449±262 ng of angiotensin I per mL per hour), whereas rat plasma renin concentration decreased to undetectable levels. Thus, chronic human renin infusion resulted in severe hypertension with extreme plasma renin activity and plasma renin concentration. However, even at these levels, human angiotensinogen was not rate limiting and angiotensin II was not a significant stimulus for angiotensinogen production. We conclude that these transgenic rats represent a novel model of human renin-dependent hypertension.

Key Words: renin • angiotensinogen • angiotensin • human • rats, transgenic • telemetry • hypertension, renin-dependent

This article has been cited by other articles:

				S. Engeli, J. Bohnke, K. Gorzelniak, J. Janke, P. Schling, M. Bader, F. C. Luft, and A. M. Sharma Weight Loss and the Renin-Angiotensin-Aldosterone System Hypertension, March 1, 2005; 45(3): 356 - 362. [Abstract] [Full Text] [PDF]

				A. C. Pereira, G. F.A. Mota, R. S. Cunha, F. L. Herbenhoff, J. G. Mill, and J. E. Krieger Angiotensinogen 235T Allele "Dosage" Is Associated With Blood Pressure Phenotypes Hypertension, January 1, 2003; 41(1): 25 - 30. [Abstract] [Full Text] [PDF]

				J. BOHLENDER, D. GANTEN, and F. C. LUFT Rats Transgenic for Human Renin and Human Angiotensinogen as a Model for Gestational Hypertension J. Am. Soc. Nephrol., November 1, 2000; 11(11): 2056 - 2061. [Abstract] [Full Text]

				J. Bohlender, S. Gerbaulet, J. Kramer, M. Gross, M. Kirchengast, and R. Dietz Synergistic Effects of AT1 and ETA Receptor Blockade in a Transgenic, Angiotensin II-Dependent, Rat Model Hypertension, April 1, 2000; 35(4): 992 - 997. [Abstract] [Full Text] [PDF]

				J. Bohlender, J. Menard, O. Edling, D. Ganten, and F. C. Luft Mouse and rat plasma renin concentration and gene expression in (mRen2)27 transgenic rats Am J Physiol Heart Circ Physiol, May 1, 1998; 274(5): H1450 - H1456. [Abstract] [Full Text] [PDF]

				A. Busjahn, H. Knoblauch, M. Knoblauch, J. Bohlender, M. Menz, H.-D. Faulhaber, A. Becker, H. Schuster, and F. C. Luft Angiotensin-Converting Enzyme and Angiotensinogen Gene Polymorphisms, Plasma Levels, Cardiac Dimensions A Twin Study: A Twin Study Hypertension, January 1, 1997; 29(1): 165 - 170. [Abstract] [Full Text] [PDF]

				J. Bohlender, A. Fukamizu, A. Lippoldt, T. Nomura, R. Dietz, J. Menard, K. Murakami, F. C. Luft, and D. Ganten High Human Renin Hypertension in Transgenic Rats Hypertension, January 1, 1997; 29(1): 428 - 434. [Abstract] [Full Text] [PDF]